{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:52:59Z","timestamp":1792011179995,"version":"4.4.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.urolonc.2025.11.011","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T12:38:58Z","timestamp":1765197538000},"page":"119.e17-119.e25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of kynurenine and tryptophan metabolism in bladder cancer: Diagnostic and prognostic implications of IDO1 polymorphism"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0731-9877","authenticated-orcid":false,"given":"Kemal","family":"Kayar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1765-919X","authenticated-orcid":false,"given":"R\u0131dvan","family":"Kayar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4962-5330","authenticated-orcid":false,"given":"Dilara","family":"S\u00f6nmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0622-7148","authenticated-orcid":false,"given":"Mehmet Tolgahan","family":"Hakan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8998-2028","authenticated-orcid":false,"given":"Cem","family":"Horozo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8161-4068","authenticated-orcid":false,"given":"\u00d6mer Ergin","family":"Y\u00fcceba\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2615-0202","authenticated-orcid":false,"given":"\u0130lhan","family":"Yayl\u0131m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5295-5410","authenticated-orcid":false,"given":"Levent","family":"Verim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2025.11.011_bib0001","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2025.11.011_bib0002","doi-asserted-by":"crossref","first-page":"1170124","DOI":"10.3389\/fonc.2023.1170124","article-title":"Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs","volume":"13","author":"Grabe-Heyne","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.urolonc.2025.11.011_bib0003","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/JU.0000000000003846","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment","volume":"211","author":"Holzbeierlein","year":"2024","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.11.011_bib0004","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3390\/cancers15030709","article-title":"Diagnostic performance of biomarkers for bladder cancer detection suitable for community and primary care settings: a systematic review and meta-analysis","volume":"15","author":"Papavasiliou","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.urolonc.2025.11.011_bib0005","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12957-024-03569-1","article-title":"The diagnostic accuracy of urine-derived exosomes for bladder cancer: a systematic review and meta-analysis","volume":"22","author":"Long","year":"2024","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.urolonc.2025.11.011_bib0006","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.euf.2024.05.024","article-title":"Diagnostic test accuracy of urinary DNA methylation-based biomarkers for the detection of primary and recurrent bladder cancer: a systematic review and meta-analysis","volume":"10","author":"Silva-Ferreira","year":"2024","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urolonc.2025.11.011_bib0007","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41416-019-0664-6","article-title":"The therapeutic potential of targeting tryptophan catabolism in cancer","volume":"122","author":"Opitz","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2025.11.011_bib0008","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.2147\/DDDT.S373780","article-title":"Targeting indoleamine dioxygenase and tryptophan dioxygenase in cancer immunotherapy: clinical progress and challenges","volume":"16","author":"Peng","year":"2022","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.urolonc.2025.11.011_bib0009","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.3390\/ijms22094403","article-title":"Kynurenine\/tryptophan ratio as a potential blood-based biomarker in non-small cell lung cancer","volume":"22","author":"Mandarano","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.urolonc.2025.11.011_bib0010","unstructured":"Hakan MT. Investigation of intermolecular relationship between Tryptophan metabolism and PD1\/PDL1 signalling pathway in non-small cell lung cancer. Molecular Medicine, 88. \u0130stanbul: \u0130stanbul University."},{"key":"10.1016\/j.urolonc.2025.11.011_bib0011","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/bju.15205","article-title":"Tryptophan-kynurenine ratio as a biomarker of bladder cancer","volume":"127","author":"Lee","year":"2021","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2025.11.011_bib0012","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.tranon.2018.11.012","article-title":"Overexpression of indoleamine 2,3-dioxygenase 1 promotes epithelial-mesenchymal transition by activation of the IL-6\/STAT3\/PD-L1 pathway in bladder cancer","volume":"12","author":"Zhang","year":"2019","journal-title":"Transl Oncol"},{"key":"10.1016\/j.urolonc.2025.11.011_bib0013","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41420-025-02489-7","article-title":"Heightened IDO1 levels predict Bacillus Calmette-Guerin failure in high-risk non-muscle-invasive bladder cancer patients","volume":"11","author":"Turdo","year":"2025","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.urolonc.2025.11.011_bib0014","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.eurpsy.2018.05.001","article-title":"Variation of genes encoding KAT1, AADAT and IDO1 as a potential risk of depression development","volume":"52","author":"Wigner","year":"2018","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.urolonc.2025.11.011_bib0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41065-022-00219-y","article-title":"Single-nucleotide polymorphisms and activities of indoleamine 2,3-dioxygenase isoforms, IDO1 and IDO2, in tuberculosis patients","volume":"159","author":"Cao","year":"2022","journal-title":"Hereditas"},{"key":"10.1016\/j.urolonc.2025.11.011_bib0016","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.eururo.2005.04.013","article-title":"Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a\/b\/c) in BCG-treated and BCG-non-treated patients","volume":"48","author":"Orsola","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.11.011_bib0017","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.urolonc.2025.11.011_bib0018","doi-asserted-by":"crossref","first-page":"19916","DOI":"10.1038\/srep19916","article-title":"Dysregulated expression of IDO may cause unexplained recurrent spontaneous abortion through suppression of trophoblast cell proliferation and migration","volume":"6","author":"Zong","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.urolonc.2025.11.011_bib0019","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1515\/CCLM.2010.105","article-title":"Simultaneous determination of serum tryptophan metabolites in patients with systemic lupus erythematosus by high performance liquid chromatography with fluorescence detection","volume":"48","author":"Xiang","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.urolonc.2025.11.011_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1453278","article-title":"Bladder cancer biomarkers: current approaches and future directions","volume":"14","author":"Ahangar","year":"2024","journal-title":"Front Oncol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925004752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925004752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T12:29:53Z","timestamp":1769257793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143925004752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1078143925004752"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.11.011","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of kynurenine and tryptophan metabolism in bladder cancer: Diagnostic and prognostic implications of IDO1 polymorphism","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}